Latest DRC News
- Details
Usually, a diabetes diagnosis begins with a label: either Type 1 or Type 2 diabetes. Patients with diabetes are typically assigned one of these two labels and then treated accordingly.
- Details
New findings from the University of Alabama at Birmingham indicate that the type of protein in the diet is not as important as the overall amount of weight loss for those with Type 2 diabetes.
- Details
In 2012, University of Alabama at Birmingham researcher Anath Shalev, M.D., reported that a decades-old blood pressure medication called verapamil completely reversed diabetes in animal models. In 2018, the team had translated these findings into a randomized, controlled, clinical trial, demonstrating significantly improved beta cell function for one year in human subjects with recent onset Type 1 diabetes. By last year, in a small follow-up study, Shalev and colleagues had found that adult Type 1 diabetes patients taking oral verapamil required less daily insulin and showed evidence of beneficial immune modulation for as long as two years after first diagnosis.
- Details
The prevalence of Type 2 diabetes in youth is increasing in the United States, primarily among minorities, with Black and Hispanic youth showing the greatest increase. Neither the reason for the increase nor the mechanism underlying the disproportionate risk in minority youth is known.
Three UAB studies look at obesity in-utero and how it affects offspring as part of four-center study
- Details
A new study, published in the Journal of the American Heart Association, suggests that what happens in the womb could determine whether the offspring will develop obesity or other metabolic diseases later in life.
- Details
More than 7 million Americans have diabetes severe enough to require daily insulin injections and frequent finger-pricks to check their blood glucose levels. Maintaining those glucose levels in the proper range is maddeningly personal.
- Details
Late last year, UAB photographer Steve Wood began to wonder if middle age was catching up with him. “I was tired all the time — I just had no energy,” he said. He was also losing weight without dieting or exercise, and was making an unusual number of trips to the bathroom.
- Details
The University of Alabama at Birmingham’s Wendy Demark-Wahnefried, Ph.D., professor and Webb Endowed Chair of Nutrition Sciences in the School of Health Professions, was awarded the 2023 Joseph F. Fraumeni, Jr. Distinguished Achievement Award from the American Society of Preventive Oncology.
- Details
For the first time, humans with newly diagnosed Type 1 diabetes, or T1D, have received two treatments called GABA and GAD that have shown promise in animal studies and in isolated human pancreas islets. This investigator-initiated clinical trial, published in Nature Communications, focused exclusively on children with recent onset T1D.
- Details
The American Stroke Association has named George Howard, DrPH, distinguished professor of Biostatistics in the University of Alabama at Birmingham School of Public Health, the winner of the David G. Sherman Lecture Award. The award recognizes lifetime contributions for investigation, management, mentorship and community service in the stroke field.